Scancell Holdings Plc

Type: Company

Name: Scancell Holdings Plc

First reported Apr 09 2013 - Updated Apr 09 2013 - 1 reports

Appointment of Non-Executive Director

What would you like us to do with the funds you've selected Scancell Holdings Plc, (AIM:SCLP), the developer of therapeutic cancer vaccines, today announces that Peter Allen, ACA, has been appointed to the Board as Non-Executive Director, with immediate ... [Published TrustNet - Apr 09 2013]

Entities: Vaccine, Peter Allen, Cancer, Skin Cancer

First reported Mar 14 2013 - Updated Mar 15 2013 - 1 reports

Scancell Holdings says latest study backs up its approach to combatting cancer

Scancell ( LON:SCLP ) has drawn attention to an article in a respected medical journal that supports the company’s approach to fighting cancers. The developer of therapeutic cancer vaccines said a new study published in The Journal of Clinical Investigation ... [Published Proactiveinvestors United Kingdom RSS feed - Mar 14 2013]

Entities: Scancell Holdings Plc, Cancer, Antibody, Immune System, T Cell

First reported Feb 06 2013 - Updated Feb 06 2013 - 1 reports

Scancell close to receiving Japanese patent protection for its groundbreaking technology

Scancell Holdings ( LON:SCLP ), London’s best performing stock last year, is close to receiving patent approval in Japan for its ImmunoBody vaccine technology. It already has protection for its intellectutal property in the US, Europe and Australia. ... [Published Proactiveinvestors United Kingdom website - Feb 06 2013]

Entities: Patent, Scancell Holdings Plc, Vaccine

First reported Jan 15 2013 - Updated Jan 15 2013 - 1 reports

Perfect storm of patent expiries and M&A will see biotech stocks outperform, says broker

The biotechnology and healthcare sector has entered a “sustained period of momentum underpinned by a perfect storm" of events, according to City broker Cenkos. In a note to clients it pointed out that large-cap pharma and diagnostic companies are hitting ... [Published Proactiveinvestors United Kingdom RSS feed - Jan 15 2013]

Entities: Cenkos Securities Plc, Biotechnology, Patent

First reported Dec 28 2012 - Updated Dec 28 2012 - 1 reports

West African Minerals Corp

2012 Winners & Losers: King Coal scuttled

If you held shares in coal producer ATH Resources ( LON:ATH ) throughout 2012 you are probably the sort of person unlucky enough to find nothing but a lump of coal in your Christmas stocking,The stock was the worst performing UK stock in 2012, starting ... [Published Proactiveinvestors United Kingdom RSS feed - Dec 28 2012]

Entities: Coal, West African Minerals Corp, Share Price, ATH Resources Plc, Enterprise Inns PLC

Quotes

...David Evans, Chairman of Scancell, commented: "We are delighted to welcome Peter to our Board as a Non-Executive Director. The Company is entering an important juncture in its development as we await results from Part 2 of our Phase I II trial on SCIB1, our innovative therapeutic vaccine for metastatic melanoma, anticipated around the end of this year. Peter's strategic oversight and broad experience of nurturing innovative life science companies will be invaluable to Scancell." The Companies of which Peter Allen is or has been a director of in the last five years are as follows: Scancell is developing therapeutic vaccines for...

Appointment of Non-Executive Director [Published TrustNet - Apr 09 2013]

"We believe that The Journal of Clinical Investigation paper supports Scancell's approach to fighting cancers, such as malignant melanoma, where T cell activation appears to be the more effective route of combating this often fatal disease,” said Dr Richard Goodfellow, joint chief executive of Scancell. "

Scancell Holdings says latest study backs up its approach to combatting cancer [Published Proactiveinvestors United Kingdom RSS feed - Mar 14 2013]

Dr. Richard Goodfellow, joint chief executive, said: "This is a further important step in the development and commercialisation of the ImmunoBody platform and provides further evidence to support the novelty of Scancell's ImmunoBody technology in another key pharmaceutical market."

Scancell close to receiving Japanese patent protection for its groundbreaking technology [Published Proactiveinvestors United Kingdom website - Feb 06 2013]

...David Paton, TyraTech's Head of European Operations, said, " We are actively seeking retail partners to distribute our product under their own store brands or through other channels under our brand. We expect the product to be launched in the first half of 2013."

This week: ACS advances learning, OMG captures growth, OVG swaps gold for POLY [Published Proactiveinvestors United Kingdom RSS feed - Dec 12 2012]